Orexo AB Invites to a Zubsolv™ (OX219) Information Meeting on September 21 in Stockholm

Published: Sep 17, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News:

Orexo (STO:ORX) today announces the invitation of analysts, investors and media to an information meeting about Zubsolv™ (OX219), a product developed for treatment of opioid dependence, this coming Friday September 21.

Date: Friday, September 21 2012

Time: 10:00am-1:00pm (lunch included)

Place: ABG, Sundal Collier AB, Regeringsgatan 65, 5 floor, Stockholm


registration ASAP to asa.henriksson@abgsc.se

Back to news